(Q44579358)

4 December 2017

title

Pharmacokinetics of trabectedin on hemodialysis: an application for the management of cancer patients with end-stage renal disease (English)

1 reference

4 December 2017

1

Juliette Thariat

1 reference

4 December 2017

Vincent Launay-Vacher

3

object named as

Vincent Launay-Vacher

1 reference

4 December 2017

author name string

Marie-Christine Etienne-Grimaldi

2

1 reference

4 December 2017

Arturo Soto-Matos

4

1 reference

4 December 2017

Carlos Fernandez-Teruel

5

1 reference

4 December 2017

Thomas Ghafari

6

1 reference

4 December 2017

Pierre-Yves Marcy

7

1 reference

4 December 2017

Gérard Milano

8

1 reference

4 December 2017

Nicole Renée

9

1 reference

4 December 2017

Lauris Gastaud

10

1 reference

4 December 2017

Antoine Thyss

11

1 reference

4 December 2017

publication date

18 August 2011

1 reference

Cancer Chemotherapy and Pharmacology

4 December 2017

published in

1 reference

4 December 2017

volume

68

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

1363-1367

1 reference

A review of trabectedin (ET-743): a unique mechanism of action.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1718-5

Metabolism of trabectedin (ET-743, Yondelis) in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1718-5

Hepatotoxicity and metabolism of trabectedin: a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1718-5

Evaluation of human plasma protein binding of trabectedin (Yondelis, ET-743).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1718-5

Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1718-5

Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1718-5

Population pharmacokinetic meta-analysis of trabectedin (ET-743, Yondelis) in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1718-5

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1718-5

Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1718-5

10.1007/S00280-011-1718-5

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference